Amrutanjan Health Care 過去の業績
過去 基準チェック /46
Amrutanjan Health Careは、平均年間2.4%の収益成長を遂げていますが、 Pharmaceuticals業界の収益は、年間 成長しています。収益は、平均年間13.4% 9.2%収益成長率で 成長しています。 Amrutanjan Health Careの自己資本利益率は16%であり、純利益率は10.9%です。
主要情報
2.4%
収益成長率
2.5%
EPS成長率
| Pharmaceuticals 業界の成長 | 17.5% |
| 収益成長率 | 9.2% |
| 株主資本利益率 | 16.0% |
| ネット・マージン | 10.9% |
| 前回の決算情報 | 30 Sep 2024 |
最近の業績更新
Recent updates
Amrutanjan Health Care (NSE:AMRUTANJAN) Is Paying Out A Dividend Of ₹1.00
Nov 19
Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 31Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 17We Think You Should Be Aware Of Some Concerning Factors In Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings
May 31Pinning Down Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) P/E Is Difficult Right Now
May 03Amrutanjan Health Care (NSE:AMRUTANJAN) Has Affirmed Its Dividend Of ₹1.00
Feb 12Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹2.60
Sep 02Amrutanjan Health Care's (NSE:AMRUTANJAN) Dividend Will Be ₹2.60
Aug 19Amrutanjan Health Care (NSE:AMRUTANJAN) Is Due To Pay A Dividend Of ₹2.60
Aug 05Amrutanjan Health Care (NSE:AMRUTANJAN) Has Announced A Dividend Of ₹1.00
Feb 17Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹1.00
Nov 08Amrutanjan Health Care (NSE:AMRUTANJAN) Will Pay A Dividend Of ₹2.60
Aug 18Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Vies For A Place In Your Dividend Portfolio: Here's Why
Apr 30Should You Be Adding Amrutanjan Health Care (NSE:AMRUTANJAN) To Your Watchlist Today?
Apr 08Introducing Amrutanjan Health Care (NSE:AMRUTANJAN), The Stock That Zoomed 162% In The Last Five Years
Mar 11Trade Alert: The Non-Executive Independent Director Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN), Govindan Raghavan, Has Just Spent ₹72k Buying A Few More Shares
Feb 24Is It Smart To Buy Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Before It Goes Ex-Dividend?
Feb 14Is Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Latest Stock Performance A Reflection Of Its Financial Health?
Feb 12Is Amrutanjan Health Care Limited (NSE:AMRUTANJAN) A Smart Choice For Dividend Investors?
Jan 30
Is There More To The Story Than Amrutanjan Health Care's (NSE:AMRUTANJAN) Earnings Growth?
Jan 17Here's Why I Think Amrutanjan Health Care (NSE:AMRUTANJAN) Is An Interesting Stock
Jan 04What Type Of Shareholders Make Up Amrutanjan Health Care Limited's (NSE:AMRUTANJAN) Share Registry?
Dec 22How Much is Amrutanjan Health Care's (NSE:AMRUTANJAN) CEO Getting Paid?
Dec 09If You Had Bought Amrutanjan Health Care (NSE:AMRUTANJAN) Stock Five Years Ago, You Could Pocket A 106% Gain Today
Nov 26Here's What We Like About Amrutanjan Health Care's (NSE:AMRUTANJAN) Upcoming Dividend
Nov 14Why Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Should Be In Your Dividend Portfolio
Oct 28Are Strong Financial Prospects The Force That Is Driving The Momentum In Amrutanjan Health Care Limited's NSE:AMRUTANJAN) Stock?
Oct 10I Ran A Stock Scan For Earnings Growth And Amrutanjan Health Care (NSE:AMRUTANJAN) Passed With Ease
Sep 22What Percentage Of Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares Do Insiders Own?
Sep 01With Amrutanjan Health Care Limited (NSE:AMRUTANJAN) It Looks Like You'll Get What You Pay For
Aug 11Have Insiders Been Selling Amrutanjan Health Care Limited (NSE:AMRUTANJAN) Shares?
Jul 29収支内訳
収支内訳
Amrutanjan Health Care の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Sep 24 | 4,378 | 475 | 537 | 0 |
| 30 Jun 24 | 4,271 | 426 | 1,048 | 0 |
| 31 Mar 24 | 4,214 | 450 | 484 | 0 |
| 31 Dec 23 | 3,946 | 440 | 398 | 0 |
| 30 Sep 23 | 3,753 | 373 | 461 | 0 |
| 30 Jun 23 | 3,865 | 432 | 973 | 0 |
| 31 Mar 23 | 3,798 | 398 | 493 | 0 |
| 31 Dec 22 | 3,860 | 418 | 500 | 0 |
| 30 Sep 22 | 3,990 | 517 | 494 | 0 |
| 30 Jun 22 | 3,986 | 588 | 1,037 | 0 |
| 31 Mar 22 | 4,059 | 672 | 505 | 0 |
| 31 Dec 21 | 3,935 | 627 | 1,211 | 0 |
| 30 Sep 21 | 3,829 | 631 | 1,159 | 0 |
| 30 Jun 21 | 3,644 | 668 | 966 | 0 |
| 31 Mar 21 | 3,330 | 612 | 497 | 0 |
| 31 Dec 20 | 2,984 | 589 | 763 | 0 |
| 30 Sep 20 | 2,811 | 474 | 777 | 0 |
| 30 Jun 20 | 2,635 | 322 | 809 | 0 |
| 31 Mar 20 | 2,617 | 251 | 834 | 0 |
| 31 Dec 19 | 2,876 | 314 | 833 | 0 |
| 30 Sep 19 | 2,751 | 274 | 804 | 0 |
| 30 Jun 19 | 2,621 | 257 | 750 | 0 |
| 31 Mar 19 | 2,535 | 250 | 756 | 0 |
| 31 Dec 18 | 2,406 | 158 | 785 | 0 |
| 30 Sep 18 | 2,335 | 168 | 762 | 0 |
| 30 Jun 18 | 2,288 | 201 | 710 | 0 |
| 31 Mar 18 | 2,203 | 200 | 671 | 0 |
| 31 Dec 17 | 2,247 | 165 | 722 | 0 |
| 31 Mar 17 | 2,240 | 211 | 710 | 0 |
| 31 Mar 16 | 1,867 | 206 | 505 | 0 |
| 31 Mar 15 | 1,666 | 149 | 468 | 0 |
| 31 Mar 14 | 1,417 | 124 | 508 | 1 |
質の高い収益: AMRUTANJAN 非現金収入 のレベルが高いです。
利益率の向上: AMRUTANJANの現在の純利益率 (10.9%)は、昨年(9.9%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: AMRUTANJANの収益は過去 5 年間で年間2.4%増加しました。
成長の加速: AMRUTANJANの過去 1 年間の収益成長率 ( 27.5% ) は、5 年間の平均 ( 年間2.4%を上回っています。
収益対業界: AMRUTANJANの過去 1 年間の収益成長率 ( 27.5% ) はPharmaceuticals業界20%を上回りました。
株主資本利益率
高いROE: AMRUTANJANの 自己資本利益率 ( 16% ) は 低い とみなされます。